Doctor profile · Federal record
Dr. Michael Schuster, MD, PHD
Rheumatology Physician (CMS: Rheumatology) · Voorhees, NJ
- NPI 1215091269
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2301 E. Evesham Road, Bldg 800, Suite 115
Voorhees, NJ 08043
(856) 424-5005
fax (856) 424-4716
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- May 16, 2018
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- New Jersey #25MA08543700
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1215091269. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
163,195
Distinct HCPCS
10
Medicare allowed
$1,912,705
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 64,800 | 46 | $5 | |
J3262 |
Injection, tocilizumab, 1 mg | 46,880 | 33 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 16,833 | 47 | $13 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,300 | 36 | $42 | |
J2356 |
Injection, tezepelumab-ekko, 1 mg | 6,720 | 11 | $18 | |
J1306 |
Injection, inclisiran, 1 mg | 6,248 | 20 | $12 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 5,556 | 49 | $32 | |
J0897 |
Injection, denosumab, 1 mg | 4,740 | 55 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 821 | 385 | $138 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 447 | 114 | $82 |
In context: peer comparison
Among 10 peers in Voorhees Rheumatology Physician, average services per provider: 3,572. This provider delivers 46× the peer median.Open Payments
Industry payments received
All-time total
$224
Transactions
9
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $133.92 | |
| Novartis Pharmaceuticals Corporation | 1 | $20.90 | |
| Abbvie INC. | 1 | $18.66 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $18.18 | |
| Regeneron Healthcare Solutions, INC. | 1 | $17.30 | |
| Amgen INC. | 1 | $14.57 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,510
Patients
662
Total drug cost
$1,712,646
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 709 | 176 | $35,701 |
| Hydroxychloroquine Sulfate | Generic | 322 | 88 | $24,106 |
| Prednisone | Generic | 274 | 87 | $2,666 |
| Alendronate Sodium | Generic | 255 | 85 | $3,177 |
| Tramadol Hcl | Generic | 225 | 52 | $2,430 |
| Allopurinol | Generic | 156 | 45 | $3,039 |
| Duloxetine Hcl | Generic | 92 | 36 | $3,109 |
| Humira(Cf) Pen (Adalimumab) | Brand | 89 | 0 | $738,830 |
| Folic Acid | Generic | 71 | 23 | $262 |
| Enbrel Sureclick (Etanercept) | Brand | 69 | 0 | $653,299 |
Hospital affiliations
Frequently asked questions
What is Dr. Michael Schuster's medical specialty?
Dr. Michael Schuster practices Rheumatology Physician in Voorhees, NJ.
Where does Dr. Michael Schuster practice?
Dr. Michael Schuster practices at 2301 E. Evesham Road, Voorhees, NJ 08043. Office phone: 8564245005.
What is Dr. Michael Schuster's NPI?
Dr. Michael Schuster's National Provider Identifier (NPI) is 1215091269, issued by NPPES.
Does Dr. Michael Schuster accept Medicare assignment?
Yes. Dr. Michael Schuster accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Schuster commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.